Found: 2
Select item for more details and to access through your institution.
Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
- Published in:
- BMC Medical Genomics, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s12920-020-00749-2
- By:
- Publication type:
- Article
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 6, p. 1022, doi. 10.1038/s41416-023-02375-y
- By:
- Publication type:
- Article